[{"Assets_0_Q3_USD":61145000.0,"CommonStockSharesOutstanding_0_Q3_shares":18673000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":5633000.0,"NetIncomeLoss_1_Q3_USD":1462000.0,"NetIncomeLoss_3_Q3_USD":-115000.0,"StockholdersEquity_0_Q3_USD":54526000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":18501000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":18358000.0,"Ticker":"FLGT","CIK":"1674930","name":"FULGENT GENETICS, INC.","OfficialName":"Fulgent Genetics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1793543393.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20191108"}]